研究業績

消化器内科

消化器内科業績

  1. 　
  2. 　
  3. 　
■英文
  1. Iwaizumi M, Taniguchi T, Kojima R, Osawa H, Tatsuta K, Sakata M, Osawa S, Kurachi K, Sugimoto K. Two independent families with de novo whole APC gene deletion and intellectual disability: a case report. Hered Cancer Clin Pract. 2025 Jan 8;23(1):1.
  2. Yamada Y, Ishida N, Takebe T, Takahashi K, Asai Y, Tamura S, Matsuura T, Takano R, Matsuura A, Yamade M, Iwaizumi M, Hamaya Y, Yamada T, Osawa S, Yoshizawa Y, Hosoda Y, Ota Y, Hanai H, Sugimoto K. Vedolizumab-steroid combination therapy improves long-term prognosis in patients with ulcerative colitis. BMC Gastroenterol. 2025 Apr 30;25(1):323.
  3. Ishida N, Onoue S, Takebe T, Takahashi K, Asai Y, Tamura S, Matsuura T, Yamade M, Iwaizumi M, Hamaya Y, Yamada T, Osawa S, Sugimoto K. Fecal Calprotectin as a Biomarker of Crohn's Disease in Patients With Short Disease Durations: A Prospective, Single-Center, Cross-Sectional Study. Gastroenterol Res Pract. 2025 Apr 25;2025:9984055.
  4. Ishida N, Tamura S, Takebe T, Takahashi K, Asai Y, Matsuura T, Yamade M, Iwaizumi M, Hamaya Y, Yamada T, Osawa S, Sugimoto K. Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn's Disease Activity: A Prospective Cross-Sectional Study. Inflamm Bowel Dis. 2025 Sep 1;31(9):2420-2428.
  5. Ishida N, Asai Y, Takebe T, Takahashi K, Sugiura K, Matsuura T, Kurihara K, Suzuki T, Honda T, Sugimoto K. IL-17A inhibitor-induced ulcerative colitis treated with an anti-IL-23 antibody. Clin J Gastroenterol. 2025 Aug;18(4):626-631.
  6. Ishida N, Takebe T, Takahashi K, Asai Y, Matsuura T, Yamade M, Iwaizumi M, Hamaya Y, Yamada T, Osawa S, Sugimoto K. Optimal positioning of biomarkers according to ulcerative colitis activity. Sci Rep. 2025 Jun 6;15(1):19916.
  7. Ishida N, Sugimoto K. Annual Infliximab Monitoring After Treatment Optimization. Dig Dis Sci. 2025 Sep;70(9):2944-2946. doi: 10.1007/s10620-025-09166-w. Epub 2025 Jun 17.
  8. Asai Y, Ishida N, Takebe T, Takahashi K, Matsuura T, Tamura S, Yamade M, Yamada T, Iwaizumi M, Hamaya Y, Osawa S, Sugimoto K. Lymphocyte Fractions as Indicators of T-Helper 1/T-Helper 2 Cytokine Profiles in Inflammatory Bowel Disease. JGH Open. 2025 Aug 11;9(8):e70243.
 
□英文(共著)
  1. Joko S, Hashimoto T, Yamashita M, Tsuriya D, Maekawa M, Iwaizumi M. Glucagon change rate after glucose load: a potential key for tailoring treatment in gestational diabetes mellitus. Diabetol Int. 2025 Jan 27;16(2):348-355.
  2. Kaneko J, Kobayashi Y, Takinami M, Kimata M, Nishino M, Takahashi Y, Yoshizawa Y, Murohisa G, Hosoda Y, Yamada T. Efficacy of e-learning using video content in improving trainees' biliary cannulation skills and understanding (with video). DEN Open. 2025 Jan 28;5(1):e70068.
  3. Yamada R, Tanaka T, Shimada Y, Owa H, Nose K, Nakamura Y, Miwata T, Tsuboi J, Hara K, Hashigo S, Hashimoto A, Hijioka S, Okamoto K, Hirooka Y, Imai H, Inoue T, Iwata K, Kamada H, Kawaguchi S, Kawashima H, Kobayashi Y, Maruta A, Mukai T, Murabayashi T, Nakashima S, Naota H, Okumura F, Oya Y, Sato J, Sugimoto K, Hamaya Y, Tano S, Yoshinari M, Imai Y, Ogura T, Tamaru S, Nakagawa H. 6-mm vs 10-mm diameter fully covered self-expandable metal stents in patients with unresectable malignant distal bile duct stricture (COSMIC UNISON): study protocol for a multicenter, randomized controlled trial. Trials. 2025 Feb 18;26(1):56.
  4. Satoh T, Kaneko J, Nakatani E, Ishiwatari H, Sato J, Ohata A, Yamada R, Miwata T, Ishikawa K, Niiya F, Kobayashi Y, Hamaya Y, Ito J, Kawata K, Suzuki A, Sakamoto Y, Ishiguro Y, Takahashi H, Kawaguchi S. Repeated pancreatic juice cytology via endoscopic nasopancreatic drainage catheter combined with clinical findings improves diagnostic ability for malignant cases of suspected pancreatic cancer with non-identifiable tumors. Pancreatology. 2025 Feb;25(1):125-133.
  5. Koizumi S, Iwaizumi M, Baba S, Ushiama M, Hirata M, Kurozumi K. Genomic analysis revealing Lynch syndrome in a case of high-grade glioma: illustrative case. J Neurosurg Case Lessons. 2025 Mar 3;9(9):CASE24718.
  6. Matsumoto T, Hisamatsu T, Esaki M, Omori T, Sakuraba H, Shinzaki S, Sugimoto K, Takenaka K, Naganuma M, Bamba S, Hisabe T, Hiraoka S, Fujiya M, Matsuura M, Yanai S, Watanabe K, Ogata H, Andoh A, Nakase H, Ohtsuka K, Hirai F, Fujishiro M, Igarashi Y, Tanaka S. Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases. Dig Endosc. 2025 Apr;37(4):319-351.
  7. Ogura Y, Shimauchi T, Sugiyama T, Sugimura Y, Nakagawa M, Osawa H, Kojima R, Iwaizumi M, Honda T. A spectrum of BAP1 expression from naevus to melanoma in a patient with BAP1 tumour predisposition syndrome. Clin Exp Dermatol. 2025 May 23;50(6):1236-1238.
  8. Ogawa-Ochiai K, Tsuji S, Maeda A, Ikehara H, Kawabata K, Dohmen T, Ojima E, Nakayama G, Hisabe T, Suenaga M, Kagaya T, Ishigure K, Okochi O, Hattori M, Hirai H, Kasai T, Takeda T, Yamada T, Yoshida I, Sakai M, Takehara A, Munemoto Y, Esaki M, Mochizuki Y, Nishijima K, Kitamura S, Sakai S, Hara T, Honyang L, Doyama H, Uchita K, Kodera Y, Yoshimura K, Mori K, Ishikawa H. A prospective, randomized, double-blind, placebo-controlled trial of the Kampo formula daiobotanpito combined with antibiotic therapy for acute diverticulitis. Sci Rep. 2025 Jul 1;15(1):21069.
  9. Ishikawa R, Yamada H, Saitsu H, Miyazaki R, Takahashi J, Takinami R, Baba S, Nakashima M, Iwaizumi M, Osawa S, Kawasaki H, Arai Y, Otsuki Y, Ogawa H, Mori H, Tanioka F, Suzuki S, Yasuda K, Suzuki M, Sugimura H, Shinmura K. Immunohistochemical and molecular evolutionary features of jejunoileal adenocarcinoma unveiled through comparative analysis with colorectal adenocarcinoma. Neoplasia. 2025 Aug;66:101180.
  10. Kojima T, Kurachi K, Iwaizumi M, Tatsuta K, Sugiyama K, Akai T, Sakata M, Morita Y, Kikuchi H, Hiramatsu Y, Takeuchi H. Adenomatous Polyposis Coli Gene Mutations, Risk Factors, and Long-term Outcomes Associated With Desmoid Tumors in Patients With Familial Adenomatous Polyposis After Colectomy in Japan. J Clin Gastroenterol. 2025 Aug 1;59(7):583-591.
  11. Sasaki A, Fujisaki J, Kobayashi M, Namikawa K, Kumazawa Y, Hoteya S, Shibagaki K, Yao K, Sugimoto M, Kawai T, Abe S, Ueyama H, Kodama M, Murakami K, Isomoto H, Ito M, Adachi K, Ohata K, Yamada T, Iwaizumi M, Kato M, Miyamoto S, Yagi K, Yao T, Yoshimura D, Miyazaki N, Ushijima T, Uemura N. Clinical Features of Invasive Gastric Cancer Developed After Helicobacter pylori Eradication During Regular Endoscopic Surveillance. Dig Endosc. 2025 Sep 28.
  12. Aoki T, Ohashi N, Uchiyama Y, Matsuyama T, Ishigaki S, Isobe S, Ishibashi M, Iwakura T, Fujikura T, Kato A, Sugimoto K, Yasuda H. Sodium appetite is enhanced in 5/6 nephrectomized rat by high-sodium diet via increased levels of angiotensin II in the subfornical organ. Hypertens Res. 2025 Oct;48(10):2595-2605.
  13. Ema C, Iwakura T, Tsuji N, Nakayama Y, Tsuchida M, Kitamura A, Katahashi N, Ishigaki S, Isobe S, Fujikura T, Ohashi N, Kato A, Sugimoto K, Yasuda H. Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury. Nephrol Dial Transplant. 2025 Oct 3:gfaf203.
  14. Tatsuta K, Honkura N, Morooka N, Sakata M, Kurachi K, Sugimoto K, Kokame K, Takeuchi H, Urano T, Suzuki Y. Microthrombi growth in ADAMTS13 deficiency exacerbates inflammatory bowel disease via mucosal and endothelial dysfunction. J Thromb Haemost. 2025 Oct 17:S1538-7836(25)00646-4.
  15. Horiuchi I, Horiuchi A, Horiuchi K, Watanabe S, Terashima T, Sugimoto K. Geboes Histopathology Score Grade 3 Subclassification Predicts Treatment Response in Active Ulcerative Colitis. J Clin Med. 2025 Oct 13;14(20):7214.
  16. Ubuka T, Kato K, Hirose T, Sugimoto K, Yamane Y. Maintenance of a High Quality of Life of a Pancreatic Cancer Patient in a Multidisciplinary Care Center: A Case Report. Case Rep Oncol Med. 2025 Nov 18;2025:1775859.
  17. Murata M, Sugimoto M, Ueshima S, Nagami Y, Ominami M, Furumoto Y, Mikami T, Sawaya M, Yoshida N, Inoue K, Maruyama Y, Terai T, Tsuji S, Yamamura T, Yamada T, Takeuchi Y, Yagi N, Osawa S, Yoshizawa Y, Orihara S, Miyamoto S, Matsuda S, Hira D, Terada T, Katsura T, Fujishiro M, Kawai T. Pharmacodynamics of direct oral anticoagulants associated with post-endoscopic delayed mucosal resection bleeding of colorectal neoplasms. Sci Rep. 2025 Dec 22.
  18. Kaneko J, Takinami M, Anma A, Suzuki D, Nishizawa K, Hirano Y, Niwa T, Kato A, Takahashi Y, Nishino M. Clinical Characteristics and Predictors of Acute Cholangitis With Enterococcal-Positive Bile Cultures: A Retrospective Study. J Hepatobiliary Pancreat Sci. 2025 Dec;32(12):893-900.
 
■和文
  1. 杉本　健　【IBD内視鏡に関するガイドラインを読み解く!】『炎症性腸疾患内視鏡診療ガイドライン』より　CQ15:UCの内視鏡的活動性評価はどのような指標が推奨されるか?　CQ16:UCにおける内視鏡的寛解の定義は何か?も含めて　IBD Research　19巻2号 Page101-104(2025.06)
  2. 岩泉 守哉, 山田 英孝, 大澤 春萌, 瀬川 麻美, 小泉 圭, 馬場 聡, 大澤 恵, 新村 和也, 竹内 裕也, 杉本 健　【遺伝性消化管疾患の内視鏡診療】遺伝性びまん性胃癌　消化器内視鏡37巻6号 Page824-827(2025.06)
  3. 岩泉 守哉　目で見てわかる遺伝病　消化器内科編　家族性大腸腺腫症(大腸病変)　 遺伝子医学　15巻3号 Page3-4(2025.09)
  4. 岩泉 守哉　目で見てわかる遺伝病　消化器内科編　遺伝性びまん性胃がん　hereditary diffuse gastric cancer　 遺伝子医学　15巻2号 Page3-4(2025.06)
  5. 岩泉 守哉　目で見てわかる遺伝病　消化器内科編　Cowden症候群/PTEN過誤腫症候群　 遺伝子医学　15巻1号 Page3-4(2025.03)
 
□和文(共著)
  1. 幸田 隆彦, 大澤 恵, 浜松医師会胃がん検診委員会　【胃内視鏡検診のITによるサポート】対策型胃内視鏡検診の立場から見たICTを用いた検診運営日本消化器がん検診学会雑誌 63巻5号 Page602-612(2025.09)

一覧に戻る